BioSig Technologies, Inc. announces its intention to offer shares of common stock through an underwritten public offering.
The company plans to use the proceeds for purchasing gold bullion, working capital, and general corporate purposes.
Clear Street and Needham & Company are the joint book-running managers of the offering.
Offering Details
The offering consists of shares of common stock (or pre-funded warrants) by BioSig Technologies, Inc.
Use of Proceeds
Intends to use net proceeds for purchasing gold bullion, working capital, and general corporate purposes.
Offering Conditions
The offering completion is subject to market conditions with uncertainty regarding timing, size, and terms.
- BioSig Technologies, Inc. aims to expand its investment in gold bullion through the public offering.
- The joint book-running managers, Clear Street and Needham & Company, will oversee the underwritten public offering.
- The offering is based on a shelf registration statement declared effective by the SEC in December 2024.
The announcement of the proposed public offering by BioSig Technologies Inc. signifies a strategic move towards expanding its investment portfolio and enhancing corporate resources.